Source BioScience

The increase was driven by a 17 percent jump in revenues for the firm's laboratory services division, offset by lower product sales.

The genomic products and services firm said that no assets or personnel will be transferred, but it will license its analysis software to Source BioScience.

The firm's lab services division saw 9 percent revenue growth, while its product sales fell 8 percent.

NEW YORK (GenomeWeb) – Source BioScience today reported that its first-half 2014 revenues increased 46 percent year over year driven by its diagnostics services business.

Lab7 Systems has released a beta version of its next-generation sequencing data workflow management software platform, available for download to early-access users from the company's website. The company is planning updates to the software every four to six weeks.

A group at the University of Oxford has begun offering a sequencing-based cancer test that uses Life Technologies' Ion Torrent PGM — the first sequencing-based product developed under the UK's Stratified Medicine Program.

Source BioScience, a UK-based genomic service provider, is focusing its R&D resources on informatics development in an effort to expand its business into the global market.

Source BioScience's DNA sequencing services business has grown by 60 percent year over year, driven by its overnight services, the UK-based company reported this week in its half-year 2012 earnings report.

NEW YORK (GenomeWeb News) – Source BioScience reported today an 11 percent increase year over year in revenues for the first half of 2012.

NEW YORK (GenomeWeb News) – Source BioScience said this week that it has extended its next-generation sequencing services to include the Illumina MiSeq platform.

Pages

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.